The state of antibiotic development: ‘Deplorable comes to mind’

Taking stock of the drug industry, from the lab to the medicine chest

May 7, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | The state of antibiotic development: 'Deplorable comes to mind' Since launching four years ago with industry backing, the AMR Action Fund has closed on 10 investments for antibiotics and antifungals. By Ed Silverman STAT+ | Compounders lose legal battle with FDA over removal of Eli Lilly's weight loss drug from a shortage list A federal judge sided with the FDA over a decision last year to remove two Lilly drugs from a shortages list maintained by the agency. By Ed Silverman STAT+ | Flatiron Health veterans raise $25 million for AI tool to forecast drug toxicity Inductive Bio's platform will help small and mid-sized biotechs developing small molecule drugs detect properties like metabolism and toxicity- By Allison DeAngelis Adobe STAT+ | Marea drug cuts type of blood fat in half in study There are currently no drugs approved that lower levels of 'remnant cholesterol' associated with cardiovascular risk. By Adam Feuerstein Opinion: The biotech industry needs to make its case for bold change to the White House The biotech industry needs to ask itself: Where does it fit in Trump's vision for a new American Golden Age? By Joe Grogan Opinion: 'It's not too late to do something': An open letter from a leading vaccine advocate to Sen. Cassidy about RFK Jr. Robert F. Kennedy Jr. holds his anti-vaccine beliefs with the strength of a religious conviction, writes rotavirus vaccine co-inventor Paul A. Offit. By Paul A. Offit

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser